Lichen Sclerosus et Atrophicus: Clinical Trials

29 trials for Lichen Sclerosus et Atrophicus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 5 unknown, 4 recruiting, 2 not yet recruiting. 12 Not applicable, 4 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 8, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 24Completed 2, Active not recruiting 1, Not yet recruiting 1
Phase 33Completed 2, Recruiting 1

Follow Lichen Sclerosus et Atrophicus: new trials by email Literature Review of Lichen Sclerosus et Atrophicus trials Research Report on Lichen Sclerosus et Atrophicus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nemolizumab for LS
Nemolizumab 30 mg - Lichen Sclerosus of Vulva
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center252026-09-012026-07-15
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Delgocitinib, Cream Vehicle - Lichen Sclerosus
Phase 3RecruitingLEO Pharma6522026-05-012026-10-13
Efficacy of Collagendep in Reducing Vulvar Dryness in Patients With Lichen Sclerosus Treated With Fat Grafting
Autologous Fat Grafting (Lipofilling), Collagendep Pink Beauty - Vulvar Lichen Sclerosus, Vulvar Atrophy
Not applicableNot yet recruitingSan Gallicano Dermatological Institute IRCCS402026-02-202026-03-04
Identification of Genetic Variants Associated With Lichen Sclerosus
No Interventions - Lichen Sclerosus Lesion
RecruitingGudula Kirtschig1002025-12-132026-07-22
Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Circumcision - Lichen Sclerosus
RecruitingRegion Västerbotten3002025-10-062026-02-10
Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation
Ruxolitinib Topical Cream - Immune-related Vitiligo-like-Depigmentation
Phase 2Active not recruitingUniversity of Zurich342024-07-252026-07-24
Vaginal Ecosystem and Network in the United States Study
Vaginal Swab Collection - Bacterial Vaginosis, Candidiasis
Enrolling by invitationVaginal Biome Science32502024-05-162025-07-01
Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus
Treatment with Monalisa Glide Laser, Treatment with Clobetasol - Lichen Sclerosus
Not applicableRecruitingKantonsspital Winterthur KSW1202023-11-102025-09-23
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
Ruxolitinib cream, Vehicle cream - Lichen Sclerosus
Phase 2CompletedIncyte Corporation612022-11-182024-09-24
Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome
Lichen Sclerosus
UnknownRegion Jönköping County2002022-01-142023-01-09
Laser vs Clobetasol for Lichen Sclerosus
Clobetasol 0.05% Emollient Top Cream, Non-ablative CO2 Laser - Lichen Sclerosus
Phase 3CompletedRuhr University of Bochum2462021-11-022025-12-04
Laser Therapy in Women With Lichenoid Disorders
Laser, Placebolaser - Lichen Sclerosus Et Atrophicus, Lichen Planus
Not applicableCompletedMedical University of Graz402020-11-172025-05-13
Effect of Treatment With the Ablative Fractional Carbodioxide Laser in Vulvar Lichen Sclerosis
Active microablative fractional CO2 laser designed as SmartXide Touch C60, CO2 laser system for MonaLisa Touch, DEKA, Florence, Sham microablative fractional CO2 laser designed as SmartXide Touch C60, CO2 laser system for MonaLisa Touch, DEKA, Florence - Lichen Sclerosus Et Atrophicus of the Vulva
Not applicableUnknownInsel Gruppe AG, University Hospital Bern642020-01-012021-08-19
Safety and Efficacy of Laser Therapy in Gynaecology
Herpes Genitalis, Genital Wart
UnknownJuna d.o.o.3002019-07-242019-08-30
MonaLisa Touch Laser for the Treatment of Vulvar Lichen Sclerosus
FxCO2 Laser, Sham Laser - Lichen Sclerosus
Not applicableCompletedCenter for Vulvovaginal Disorders402018-08-282020-11-12
a Flexible Wound Dressing for the Management of Genital Skin Conditions
Film forming silicone gel (7-0940) - Vaginitis, Atrophic Vaginitis
Not applicableCompletedStratpharma AG542018-01-312022-05-31
Lichen Sclerosus - the Influence on Quality of Life
Standard care and sexological counseling - Lichen Sclerosus
Not applicableCompletedRegionshospital Nordjylland1582018-01-042020-05-27
Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Genitourinary Syndrome of Menopause, Pelvic Floor Dysfunction
Completed1st Federal Budgetary Healthcare Institution Volga District Medical Center602018-01-012022-02-22
Biomarkers of Lichen Sclerosus
Lichen Sclerosus
UnknownCenter for Vulvovaginal Disorders582017-11-272018-06-19
Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus
Fractional / Pixel CO2 Laser - Vaginal Atrophy, Lichen Sclerosus
Not applicableCompletedHadassah Medical Organization162017-09-012019-08-06

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Vulvar Lichen Sclerosus (6)  ·  Lichen Planus (5)  ·  Vulvar Diseases (4)  ·  Vulvodynia (4)  ·  Neoplasms (2)  ·  Vulvar Neoplasms (2)  ·  Atrophic Vaginitis (1)  ·  Candidiasis (1)  ·  Carcinoma, Squamous Cell (1)  ·  Condylomata Acuminata (1)  ·  Disease (1)  ·  Endometriosis (1)  ·  Herpes Genitalis (1)  ·  Hidradenitis Suppurativa (1)

Broader conditions

Lichenoid Eruptions (29)  ·  Skin Diseases, Papulosquamous (29)  ·  Skin and Connective Tissue Diseases (29)  ·  Skin Diseases (28)  ·  Female Urogenital Diseases (13)  ·  Female Urogenital Diseases and Pregnancy Complications (13)  ·  Genital Diseases (13)  ·  Genital Diseases, Female (13)  ·  Urogenital Diseases (13)  ·  Vulvar Diseases (7)  ·  Male Urogenital Diseases (3)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Female (2)

Interventions

Clobetasol (4)  ·  Circumcision, Male (1)  ·  Lasers (1)  ·  Lasers, Solid-State (1)  ·  Ointments (1)  ·  Photography (1)  ·  Standard of Care (1)  ·  Therapeutics (1)  ·  delgocitinib (1)  ·  nemolizumab (1)  ·  pimecrolimus (1)  ·  ruxolitinib (1)

Sponsors

Center for Vulvovaginal Disorders (5)  ·  Northwestern University (2)  ·  1st Federal Budgetary Healthcare Institution Volga District Medical Center (1)  ·  Dr Adolf Lukanovič (1)  ·  Ginekološka Poliklinika Dr. Vesna Harni (1)  ·  Gloucestershire Hospitals NHS Foundation Trust (1)  ·  Gudula Kirtschig (1)  ·  Hadassah Medical Organization (1)  ·  Incyte Corporation (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Juna d.o.o. (1)  ·  Kantonsspital Winterthur KSW (1)  ·  LEO Pharma (1)  ·  Medical University of Graz (1)  ·  Medstar Health Research Institute (1)

Countries

United States (11)  ·  Switzerland (4)  ·  Canada (3)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Croatia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Israel (1)  ·  Russia (1)  ·  Slovenia (1)

Top investigators

Andrew T Goldstein, MD (3)  ·  Bethanee J Schlosser, MD, PhD (2)  ·  Andrew Goldstein, MD (1)  ·  Annika Bergman, PhD (1)  ·  Charles Macri, MD (1)  ·  Cheryl Iglesia, MD (1)  ·  Clemens B Tempfer, MD (1)  ·  Gesine Meili, MD (1)  ·  Gudula Kirtschig, Dr. (1)  ·  Haq Nawaz, MD (1)  ·  Kimberly Capone, PhD (1)  ·  Laura Knabben, Dr. med. (1)

Results publications

PMID 12418071, PMID 15568399, PMID 16130842, PMID 16176512, PMID 20522071, PMID 20868406, PMID 21353334, PMID 25608255, PMID 33957642, PMID 33957648, PMID 35333024, PMID 39035147, PMID 42208069

NIH funding

2023 (1), 2025 (1)